Ignite Creation Date:
2024-05-05 @ 11:37 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00099346
Status:
TERMINATED
Last Update Posted:
2015-06-17
First Post:
2004-12-10
Brief Title:
MK0457 an Aurora Kinase Inhibitor Study in Patients With Advanced Colorectal Cancer and Other Advanced Solid Tumors 0457-001
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Study Overview
Official Title:
A Phase IIIa Study Evaluating the SafetyTolerability Pharmacokinetics and Efficacy of MK0457 Administered as a 5-Day Continuous Infusion in Patients With Advanced Colorectal Cancer and Other Solid Tumors
Status:
TERMINATED
Status Verified Date:
2015-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Study with an investigational drug in patients with recurrent or non-responsive colorectal cancer or other advanced solid tumors
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
This is an early phase trial and some specific protocol information is proprietary and not publicly available at this time Full information is available to trial participants
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004_095 | None | None | None |
| MK0457-001 | None | None | None |